Hepatitis B Virus Infection: Current Trends and Issues

Norihiro Furusyo, Motohiro Shimizu, Eijchi Ogawa, Masayuki Murata, Jun Hayashi

Research output: Contribution to journalReview article

Abstract

Hepatitis B virus (HBV) infection is a global public health problem. HBV has been classified into eight genotypes (A to H) based on complete nucleotide sequencing. The prevalence of specific genotype varies geographically. The rationale for treatment in patients with chronic hepatitis B is to reduce the risk of progressive chronic liver disease, such as cirrhosis and hepatocellular carcinoma. Treatment strategies for chronic HBV infection include interferon and nucleotide analogues (lamivudine, adefovir dipivoxil, entecavir, and tenofovir disoproxil). HBV persists in the body even after serological recovery from acute hepatitis B. Thus, individuals who have been exposed to HBV are at risk of the reactivation of infection, which may result in an increase in serum aminotransferases or a flare when the immune response is suppressed. Patients requiring immunosuppressive therapy should undergo serologic testing for markers of HBV infection. This topic review summarizes these issues related to the management of hepatitis B.

Original languageEnglish
Pages (from-to)755-761
Number of pages7
JournalRinsho byori. The Japanese journal of clinical pathology
Volume63
Issue number6
Publication statusPublished - Jun 1 2015

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Fingerprint Dive into the research topics of 'Hepatitis B Virus Infection: Current Trends and Issues'. Together they form a unique fingerprint.

  • Cite this